Breast cancer research in Asia: adopt or adapt Western knowledge?

作者: Nirmala Bhoo-Pathy , Cheng-Har Yip , Mikael Hartman , Cuno S.P.M. Uiterwaal , Beena C.R. Devi

DOI: 10.1016/J.EJCA.2012.09.014

关键词:

摘要: Abstract The incidence and mortality of breast cancer continues to rise rapidly in Asian countries. However, most our current knowledge on has been generated Western populations. As the socio-economic profile, life style culture women are substantially different, genetic backgrounds vary some extent, we need answer question whether ‘adopt’ or ‘adapt’ before applying it setting. It is generally accepted that risk factors, which have mainly studied populations similar worldwide. presence gene–environment gene–gene interactions may alter their importance as causal factors across Diagnostic prognostic study findings, including prediction rules, increasingly shown be ‘setting specific’ must therefore validated implementing them clinical care Asia. Interventional research findings from Caucasian patients not applicable Asia due differences tumour biology/profiles, metabolism drugs also health beliefs can influence treatment acceptance adherence. While warranted all domains medical research, felt for patients, needs highest diagnostic studies. International trials meanwhile include various settings provide an insight into effectiveness new modalities this part world.

参考文章(58)
T Hoare, Breast screening and ethnic minorities. The British journal of cancer. Supplement. ,vol. 29, ,(1996)
DAVID L Sackett, R BRIAN Haynes, The architecture of diagnostic research BMJ. ,vol. 324, pp. 539- 541 ,(2002) , 10.1136/BMJ.324.7336.539
Writing Group for the Women's Health Initiative Investigators, Writing Group for the Women's Health Initiative Investigators, None, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial JAMA. ,vol. 288, pp. 321- 333 ,(2002) , 10.1001/JAMA.288.3.321
Freddie Bray, Peter McCarron, D Maxwell Parkin, The changing global patterns of female breast cancer incidence and mortality Breast Cancer Research. ,vol. 6, pp. 229- 239 ,(2004) , 10.1186/BCR932
Peter M. Ravdin, Laura A. Siminoff, Greg J. Davis, Mary Beth Mercer, Joan Hewlett, Nancy Gerson, Helen L. Parker, Computer Program to Assist in Making Decisions About Adjuvant Therapy for Women With Early Breast Cancer Journal of Clinical Oncology. ,vol. 19, pp. 980- 991 ,(2001) , 10.1200/JCO.2001.19.4.980
Woon-Puay Koh, David Van Den Berg, Aizhen Jin, Renwei Wang, Jian-Min Yuan, Mimi C. Yu, Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore. Breast Cancer Research and Treatment. ,vol. 130, pp. 1011- 1019 ,(2011) , 10.1007/S10549-011-1680-2
Gaurav Agarwal, P. V. Pradeep, Vivek Aggarwal, Cheng-Har Yip, Polly S. Y. Cheung, Spectrum of Breast Cancer in Asian Women World Journal of Surgery. ,vol. 31, pp. 1031- 1040 ,(2007) , 10.1007/S00268-005-0585-9
Konstantinos P. Economopoulos, Theodoros N. Sergentanis, Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: a meta-analysis Breast Cancer Research and Treatment. ,vol. 120, pp. 211- 216 ,(2010) , 10.1007/S10549-009-0467-1
Hyo Sook Han, Isildinha M. Reis, Wei Zhao, Katsumasa Kuroi, Masakazu Toi, Eiji Suzuki, Rachel Syme, Louis Chow, Adrian Y.S. Yip, Stefan Glück, Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer European Journal of Cancer. ,vol. 47, pp. 2537- 2545 ,(2011) , 10.1016/J.EJCA.2011.06.027
N. Bhoo Pathy, H. M. Verkooijen, N. A. Taib, M. Hartman, C. H. Yip, Impact of breast surgery on survival in women presenting with metastatic breast cancer British Journal of Surgery. ,vol. 98, pp. 1566- 1572 ,(2011) , 10.1002/BJS.7650